<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONSOLIDATED BALANCE SHEET AS OF MARCH 31, 1996 AND THE CONSOLIDATED STATEMENT OF OPERATIONS FOR THE YEAR ENDED MARCH 31, 1996 OF MEDISENSE, INC. AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS INCLUDED IN FORM-10K FOR THE FISCAL YEAR ENDED MARCH 31, 1996. </LEGEND> <MULTIPLIER> 1,000 <CURRENCY> U.S. DOLLARS <PERIOD-TYPE> YEAR <FISCAL-YEAR-END> MAR-31-1996 <PERIOD-START> APR-01-1995 <PERIOD-END> MAR-31-1996 <EXCHANGE-RATE> 1 <CASH> 24,114 <SECURITIES> 26,984 <RECEIVABLES> 28,221 <ALLOWANCES> 1,091 <INVENTORY> 14,634 <CURRENT-ASSETS> 97,214 <PP&E> 38,901 <DEPRECIATION> 19,662 <TOTAL-ASSETS> 121,182 <CURRENT-LIABILITIES> 35,536 <BONDS> 0 <COMMON> 177 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <OTHER-SE> 83,649 <TOTAL-LIABILITY-AND-EQUITY> 121,182 <SALES> 173,756 <TOTAL-REVENUES> 173,756 <CGS> 57,146 <TOTAL-COSTS> 57,146 <OTHER-EXPENSES> 82,808 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 127 <INCOME-PRETAX> 35,371 <INCOME-TAX> 3,537 <INCOME-CONTINUING> 31,834 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 31,834 <EPS-PRIMARY> 1.70 <EPS-DILUTED> 1.68